Chison Medical Technologies Co., Ltd. (SHA:688358)

SHA:688358 Cash Flow Statement

Financials in millions CNY. Fiscal year is January - December.

Operating Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	120.91	116.5	140.51	146.48	105.84	112.47
Depreciation & Amortization	13.6	13.6	14.78	14.26	13.03	9.89
Other Amortization	0.89	0.89	0.26	0.04	0.13	0.24
Loss (Gain) From Sale of Assets	-4.53	-4.53	-4.61	-3.02	0.5	-30.25
Asset Writedown & Restructuring Costs	-	-	-	0.06	0.51	1.58
Loss (Gain) From Sale of Investments	-3.43	-3.43	-6.29	-11.17	-15	-17.53
Provision & Write-off of Bad Debts	1.47	1.47	1.7	3.58	-1.4	0.74
Other Operating Activities	-26.24	16.11	-16.92	-19.06	-15.19	6.22
Change in Accounts Receivable	-35.68	-35.68	-1.01	-78.87	37.02	-1.55
Change in Inventory	-7.03	-7.03	5.65	56.08	-100.41	-16.76
Change in Accounts Payable	12.05	12.05	7.83	-20.33	41.92	-25.33
Change in Other Net Operating Assets	-0.06	-0.06	-2.03	-2.92	-0.82	1.37
Operating Cash Flow	69.23	107.17	140.68	85.91	63.74	39.96
Operating Cash Flow Growth	-48.86%	-23.82%	63.76%	34.78%	59.51%	-51.53%

Investing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Capital Expenditures	-15.19	-14.41	-8.85	-34.01	-52.21	-39.19
Sale of Property, Plant & Equipment	4.37	5.57	5.01	3.71	0.09	21.17
Investment in Securities	178.47	57.16	535.7	-236.03	-	165
Other Investing Activities	8.09	9.5	23.68	25.15	6.69	17.1
Investing Cash Flow	175.74	57.82	555.53	-241.18	-45.43	164.09

Financing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Long-Term Debt Repaid	-	-4.4	-4.3	-0.95	-0.93	-0.61
Net Debt Issued (Repaid)	-4.4	-4.4	-4.3	-0.95	-0.93	-0.61
Issuance of Common Stock	3.74	3.74	-	-	2.02	-
Repurchase of Common Stock	-	-	-	-10.1	-	-
Common Dividends Paid	-145.51	-111.87	-89.5	-78.49	-40	-64
Other Financing Activities	0.71	-	-	-	-	-
Financing Cash Flow	-145.46	-112.54	-93.8	-89.53	-38.91	-64.61

Net Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Foreign Exchange Rate Adjustments	-43.06	-30.54	12.24	9.34	21.59	-2.99
Net Cash Flow	56.44	21.91	614.64	-235.47	0.99	136.45

Free Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Free Cash Flow	54.04	92.76	131.83	51.9	11.53	0.78
Free Cash Flow Growth	-57.38%	-29.64%	154.02%	350.04%	1386.91%	-98.50%
Free Cash Flow Margin	12.41%	21.29%	28.13%	10.73%	3.03%	0.19%
Free Cash Flow Per Share	0.48	0.83	1.18	0.47	0.10	0.01
Levered Free Cash Flow	-28.28	53.66	105.05	-2.85	-16.31	5.74
Unlevered Free Cash Flow	-28.09	53.86	105.28	-2.63	-16.24	5.78

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash Income Tax Paid	-	-7.52	-2.42	0.48	-6.43	-14.31
Change in Working Capital	-33.45	-33.45	11.26	-45.26	-24.68	-43.4

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 12, 2026

Data Sources Report a data error